EducationHow a lab checks a vial
Mass Spectrometry: How Labs Confirm a Peptide's Identity
Written by Julia Piccoli, PhD
Associate R&D Director, Kemin Industries LATAM · Published · 6 min read
Mass spectrometry supports peptide identity by comparing observed m/z values, an ion’s mass divided by its charge number, with those expected for the peptide. It answers a different question from HPLC purity: one dominant chromatographic peak does not prove what that component is.

In this article+−
What does a mass spectrometer measure?
A mass spectrometer measures gas-phase ions (molecules carrying an electrical charge), not the mass of a neutral peptide directly. The reported quantity is m/z: an ion’s mass relative to the unified atomic mass unit, divided by its charge number. IUPAC treats m/z as dimensionless.
Masses here are in daltons, where a molecule's mass in daltons is the same number as its molar mass in grams per mole. Identity checks use the monoisotopic mass, built from the most common isotope of each element, rather than the average mass printed on labels; why a peptide has two kinds of mass explains the difference.
Instruments measure m/z in different ways, by flight time, by filtering in electric fields or by orbit frequency, but they all report the same kind of number.
Why can one peptide produce several peaks?
Because a peptide can carry more than one charge. The usual way to turn peptides into ions is electrospray ionization, which John Fenn published in 1988 and which earned him a share of the 2002 Nobel Prize in Chemistry. It sprays the liquid into a fine, charged mist, and peptides emerge carrying extra protons, often more than one.
Each extra proton changes the m/z. A peptide carrying one proton appears at its mass plus one proton. Carrying two, it appears at its mass plus two protons, divided by two, and so on. One molecule produces a series of peaks, one per charge state, written [M+H]+, [M+2H]2+ and so on. The Nobel Prize's own popular account of the award makes the same point: one molecule gives a series of peaks because each copy can take up a different number of charges.
Each of those peaks also has a few small neighbors just above it, from molecules containing a heavier isotope.
What is LC-MS?
LC-MS joins two complementary techniques: HPLC separates the sample, UV detection records the response at the chosen wavelength, and the mass spectrometer measures the m/z values of components that ionize as they leave the column. Because the mass signal is linked to retention time, the laboratory can assess whether the main chromatographic peak, the component on which the purity result is based, also has the expected mass. This pairing is more specific than retention time alone; ICH Q6A notes that identification by a single chromatographic retention time is not considered specific, while a combined procedure such as HPLC/MS is generally acceptable.
- LC columnSeparates the sample over time.
- UV detectorRecords the response at the chosen wavelength.
- Mass spectrometerMeasures the m/z of the ions that form.
Two signals from one run
Mass spectrum across the main peak
Schematic, not real data
The UV and MS profiles may not look identical because compounds differ in UV absorption and ionization. Co-elution, ion suppression, sodium or potassium adducts, and in-source fragments can add or hide signals. When a result is unclear, first verify the molecular formula, salt or adduct assumption, mass definition, charge assignment, and isotope spacing. Then check whether the proposed ion and its related charge states follow the main chromatographic peak across the extracted-ion chromatogram or spectrum. A consistent signal across the peak is stronger evidence than a weak feature in a single scan.
The conclusion must match the evidence reported. A certificate may state that identity was confirmed while omitting the spectrum, processing approach, observed m/z values, or tolerance. That records the laboratory’s result, but an independent technical review requires the underlying data and method criteria.
LC-MS is therefore not an automatic identity answer: confidence depends on separation, ionization, instrument performance, data processing, and predefined acceptance criteria. For example, two peptide isomers can have the same mass and the same UV signal, making them indistinguishable by these measurements alone if they also elute together. Additional characterization is therefore necessary to determine whether an isomeric form is present.
RelatedHow HPLC measures purity
What would BPC-157 look like?
PubChem gives BPC-157 (formula C62H98N16O22) a monoisotopic mass of 1418.704. Adding the mass of a proton, 1.007276 in CODATA's latest values, gives the m/z at which each charge state would appear:
[M+H]+
Calculation
1418.704 + 1.007276
Expected m/z
1419.711
[M+2H]2+
Calculation
(1418.704 + 2 × 1.007276) ÷ 2
Expected m/z
710.359
[M+3H]3+
Calculation
(1418.704 + 3 × 1.007276) ÷ 3
Expected m/z
473.909
The relative abundance of these ions depends on both the peptide sequence and the ionization conditions. BPC-157 contains a limited number of strong protonation sites, consisting primarily of the free N-terminus and a single lysine residue. Consequently, the singly and doubly charged ions would generally be expected to dominate, whereas the triply charged ion may be present at lower abundance. Nevertheless, the actual charge-state distribution is method-dependent and should be confirmed experimentally from the acquired mass spectrum rather than inferred solely from sequence characteristics.
Expected ions for BPC-157
Illustrative sketch, not real data
The BPC-157 certificate in the certificate of analysis library reports "Identity Confirmation (LC-MS)" with a specification of BPC-157 and a result of BPC-157, ticked as passed. It doesn't print the spectrum or the observed masses, so the line records the lab's conclusion rather than the measurement behind it.
BPC-157 on this siteBPC-157 ReferenceBPC-157 ResearchRegeneration Peptides
How close must the observed mass be?
The lab compares the observed m/z with the expected one and accepts the match if it falls within a set tolerance. Tolerances are usually given in parts per million (ppm). At m/z 710, a 5 ppm window is about plus or minus 0.0036.
What's achievable depends on the instrument. A review by Kind and Fiehn reports high-resolution instruments routinely reaching below 1 ppm, with others in the 5 to 10 ppm range; simpler instruments work in much wider windows. A tight window rules out more alternatives, so a match means more on a high-resolution instrument.
One classic slip: mixing up mass types. Using BPC-157's average mass, 1419.5, instead of the monoisotopic mass would put the expected [M+2H]2+ about 0.4 away from where it really appears, which is far outside any high-resolution tolerance.
The acceptance window needs to be established from the expected performance of the instrument, taking into account routine calibration performance, method qualification or validation data, and the analytical objective of the study. The selected tolerance should ensure reliable identification of the target peptide while maintaining appropriate discrimination from unrelated species.
What can't a mass check tell you?
A matching intact mass supports identity, but it does not prove every structural feature.
The same intact mass can occur in peptides that differ by:
- leucine and isoleucine, which have the same elemental formula and mass;
- the same residues in a different order;
- some different residue combinations that have the same total composition: glycine plus alanine has the same formula as glutamine;
- a D-residue instead of the expected L-residue;
- certain structural changes, such as conversion of aspartate to isoaspartate, that do not change the total mass.
Intact mass therefore supports composition but cannot independently establish sequence, residue order, or stereochemistry.
Frequently Asked Questions
What does m/z mean in mass spectrometry?+−
m/z is the mass of an ion relative to the unified atomic mass unit, divided by its charge number. A singly charged peptide appears near its molecular mass, while a doubly charged form appears near half that value. This is why the same peptide can produce several m/z signals.
What is the difference between HPLC and LC-MS?+−
HPLC separates sample components and commonly measures ultraviolet response. LC-MS connects the separation to a mass spectrometer, adding m/z information about components that ionize and reach the MS detector. HPLC purity and LC-MS identity are complementary results, but neither automatically replaces the other.
Does an LC-MS identity result prove the peptide sequence?+−
No. A matching intact mass supports the proposed identity, but different residue orders, isobaric substitutions, and stereochemical variants may share that mass. Sequence information generally requires MS/MS or another appropriate structural method. Some distinctions, including chirality, require methods specifically capable of resolving them.
Sources
- Murray KK, Boyd RK, Eberlin MN, et al. Definitions of terms relating to mass spectrometry (IUPAC Recommendations 2013). Pure and Applied Chemistry 2013;85(7):1515-1609 doi.org/10.1351/PAC-REC-06-04-06
- Banerjee S, Mazumdar S. Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte. International Journal of Analytical Chemistry 2012;2012:282574 doi.org/10.1155/2012/282574
- The Nobel Prize in Chemistry 2002, press release and popular information nobelprize.org/prizes/chemistry/2002/popular-information
- NIST, CODATA recommended values (2022), proton mass in u physics.nist.gov/cgi-bin/cuu/Value?mpu
- PubChem compound record, BPC-157 (CID 9941957) pubchem.ncbi.nlm.nih.gov/compound/9941957
- PubChem compound record, L-leucine (CID 6106) pubchem.ncbi.nlm.nih.gov/compound/6106
- PubChem compound record, L-isoleucine (CID 6306) pubchem.ncbi.nlm.nih.gov/compound/6306
- Kind T, Fiehn O. Advances in structure elucidation of small molecules using mass spectrometry. Bioanalytical Reviews 2010;2:23-60 doi.org/10.1007/s12566-010-0015-9
- Schulte D, Snijder J. A handle on mass coincidence errors in de novo sequencing of antibodies by bottom-up proteomics. Journal of Proteome Research 2024;23(8):3552-3559 doi.org/10.1021/acs.jproteome.4c00188
- Okyem S, Sweedler JV. Recent advancements in the characterization of D-amino acid and isoaspartate post-translational modifications. Mass Spectrometry Reviews 2026;45(2):218-230 doi.org/10.1002/mas.21916
- ICH Q6A, Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances (1999), section 3.2.1 database.ich.org/sites/default/files/Q6A%20Guideline.pdf
Worked example
The article borrows BPC-157 from the catalogue to show the idea on a real molecule.
Shop lot-tested BPC-157
View Product · BPC-157The document in this article
BPC-157 certificate of analysisKovera Labs report KVR-2026-BB7E5F, batch PP/BPC/062026
Open the PDF
